Drug Trial Radar · NCT05891249
A Study to Evaluate the Safety and Effectiveness of Luspatercept for the Treatment of Transfusion-dependent (TD) Anemia Associated With Myelodysplastic Syndromes (MDS) & Beta-thalassemia (β-Thal) in India
Last checked: Nov 20, 2026Latest source record: Aug 31, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Active, not recruiting
Enrollment
85
Planned (sponsor's estimate)
Start
Jun 5, 2023
Primary completion
Dec 16, 2028
Study completion Dec 16, 2028
Sponsor
- Lead sponsor
- Bristol-Myers SquibbBristol Myers Squibb (BMY)
- Sponsor type
- Industry
- First posted
- Jun 6, 2023
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Non randomized
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- No
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and effectiveness of luspatercept in participants who require regular blood cell transfusions due to b-thalassemia and myelodysplastic syndromes in India
Conditions
- Anemia
Interventions
LuspaterceptBiological
Specified dose on specified days
Primary outcomes
What the sponsor says the trial is designed to measure.
- β-Thal Cohort: Number of participants with treatment-related adverse events (AEs) of grade 3 or higherTime frame: Up to 57 weeks
- MDS-Ring Sideroblasts (RS) Cohort: Number of participants with treatment-related AEs of grade 3 or higherTime frame: Up to 54 weeks
Locations
9 sites in 1 country. Site status is shown where the registry gives one.
Local Institution - 0005
Assam, India
Local Institution - 0003
Bangalore, India
Local Institution - 0004
Chandigarh, India
Local Institution - 0010
Delhi, India
Local Institution - 0006
Hyderabad, India
Local Institution - 0008
Mumbai, India
Local Institution - 0002
Ahmedabad, Gujarat, India
Local Institution - 0001
New Delhi, National Capital Territory of Delhi, India
Local Institution - 0007
Kolkata, West Bengal, India
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.